3-phenyllactic acid has been researched along with Multiple Sclerosis in 1 studies
3-phenyllactic acid: alpha-hydroxy analog of phenylalanine; RN given refers to cpd without isomeric designation
3-phenyllactic acid : A 2-hydroxy monocarboxylic acid that is lactic acid in which one of the methyl hydrogens is substituted by a phenyl group.
Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oezguen, N | 1 |
| Yılmaz, V | 1 |
| Horvath, TD | 1 |
| Akbayir, E | 1 |
| Haidacher, SJ | 1 |
| Hoch, KM | 1 |
| Thapa, S | 1 |
| Palacio, J | 1 |
| Türkoğlu, R | 1 |
| Kürtüncü, M | 1 |
| Engevik, MA | 1 |
| Versalovic, J | 1 |
| Haag, AM | 1 |
| Tüzün, E | 1 |
1 other study available for 3-phenyllactic acid and Multiple Sclerosis
| Article | Year |
|---|---|
Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios.
Topics: B-Lymphocyte Subsets; Fingolimod Hydrochloride; Humans; Interleukin-4; Multiple Sclerosis | 2022 |